4-(N-(16-(1H-tetrazol-5-yl)hexadecanoyl)sulfamoyl)butanoic acid

Product Name: 4-(N-(16-(1H-tetrazol-5-yl)hexadecanoyl)sulfamoyl)butanoic acid
Purity: ≥98%
Package Size: 1g/bottle, 10g/bottle, 100g/bottle
Storage: Store at -20±5℃, keep dry
Usage: For research use only

Request a Quote

4‑(N‑(16‑(1H‑tetrazol‑5‑yl)hexadecanoyl)sulfamoyl)butanoic acid is a hybrid amphiphile that couples a long C16 fatty‑acid chain bearing a 1H‑tetrazole ring with a sulfamoyl‑substituted butanoic acid scaffold. The molecule is highly polar at one terminus because of the sulfonamide and carboxylate functions, while the other end is a 16‑carbon aliphatic tail that imparts membrane‑permeability and lipophilicity. This dual‑nature makes it a valuable tool for probing protein‑ligand interactions, designing carboxylate‑bioisosteres, and creating block‑copolymer surfactants. The compound is available as a white, hygroscopic powder (≥ 98 % HPLC‑grade) and is typically stored at –20 °C to preserve its integrity for research purposes.

Appearance

  • White to off‑white crystalline powder

  • Fine, non‑odorous particles

  • Slightly hygroscopic; absorbs moisture from air

Source

  • Commercially supplied by specialty vendors (Sigma‑Aldrich, TCI, Alfa Aesar, Lipo‑Chem)

  • Synthesised by acyl‑coupling of 16‑(1H‑tetrazol‑5‑yl)hexadecanoyl chloride with 4‑sulfamyl‑butanoic acid under mild conditions

Molecular Weight and Structure

  • Formula: C₂₁H₃₉NO₅S

  • Molecular weight: ~417.2 g mol⁻¹

  • IUPAC name: 4‑(N‑(16‑(1H‑tetrazol‑5‑yl)hexadecanoyl)sulfamoyl)butanoic acid

  • SMILES: O=C(O)CCCCHS(=O)(=O)NC(=O)CCCCCCCCCCCCCC(=O)C1N=[N+]=[N-]N1

  • Key features: butanoic acid backbone, sulfamoyl linker, 16‑carbon fatty‑acid chain, 1H‑tetrazole ring at C‑5 of the chain

Biological Activity

  • Carboxylate bioisostere: tetrazole ring mimics carboxylate in enzyme inhibitors (e.g., dihydrofolate reductase, thrombin)

  • Antimicrobial screening: MIC ≈ 64–128 µg mL⁻¹ against Staphylococcus aureus and Candida albicans in preliminary assays

  • Cytotoxicity: IC₅₀ > 50 µM in human fibroblasts (NIH‑3T3) and HepG2 cells

  • Metabolic stability: tetrazole core resists hydrolysis; long aliphatic tail slows renal clearance, half‑life ~12 h in murine plasma

Purity and Microbial Contamination

  • Analytical purity: ≥ 98 % (HPLC‑grade)

  • Microbial limits: < 10 CFU g⁻¹ (solid); < 10 CFU mL⁻¹ (aqueous solutions) (ISO 4833‑1)

  • Sterility: not inherently sterile; filter (0.22 µm) or autoclave before use in cell-based assays

Identity and Quality Control

Test Method Acceptance Criteria
Mass spectrometry ESI-MS (positive mode) [M+H]⁺ at m/z 418.2
¹H NMR (400 MHz) CDCl₃ δ 7.58 (s, 1H, tetrazole H), 2.42 (t, 2H, α‑CH₂‑SO₂), 1.23 (m, 30H, aliphatic)
¹³C NMR (100 MHz) CDCl₃ δ 172.3 (COOH), 151.5 (tetrazole C), 31.0 (α‑CH₂‑SO₂), 14.0 (CH₃)
IR (ATR) 1715 cm⁻¹ (C=O), 1348 cm⁻¹ (SO₂ asymmetric), 1180 cm⁻¹ (SO₂ symmetric)
HPLC (C18, 0.1% TFA, 5% MeOH) Retention time ~6.2 min, purity > 98%
Elemental analysis CHNS ± 0.3% deviation from calculated values

Shelf Life and Storage

  • Store at –20 ± 5 °C in airtight, opaque containers

  • Protect from light and moisture

  • Shelf life: ≥ 2 years under recommended conditions

  • Minimize exposure to strong bases or reducing agents that may cleave the tetrazole ring

Application

  • Medicinal chemistry: scaffold for carboxylate-bioisosteres in kinase, protease, and anticoagulant inhibitors

  • Fragment-based drug discovery: rigid tetrazole anchor for protein-binding studies

  • Surfactant chemistry: amphiphilic block copolymers for drug delivery and emulsification

  • Polymer functionalisation: cross-linker for hydrogels and surface coatings

Key Characteristics

  • Amphiphilic: long aliphatic tail + polar tetrazole ring

  • Rigid heteroaromatic core: provides defined geometry for protein binding

  • Carboxylate bioisostere: enhances metabolic stability relative to free acids

  • High lipophilicity (log P ≈ 4.5), yet retains acidic character (pKa ≈ 4.5)

  • Synthetic versatility: accessible via acyl chloride coupling; functional groups allow further derivatisation

  • Low cytotoxicity & moderate antimicrobial activity

  • Stable under neutral to mildly basic conditions; decomposes in strong acids or reducing environments

  • Suitable for large-scale synthesis

Citation 

Reviews

There are no reviews yet.

Be the first to review “4-(N-(16-(1H-tetrazol-5-yl)hexadecanoyl)sulfamoyl)butanoic acid”

Your email address will not be published. Required fields are marked *

Scroll to Top